Literature DB >> 12063096

Citation of randomized evidence in support of guidelines of therapeutic and preventive interventions.

Ioannis A Giannakakis1, Anna Bettina Haidich, Despina G Contopoulos-Ioannidis, George N Papanikolaou, Maria S Baltogianni, John P A Ioannidis.   

Abstract

Guideline statements may be supported by evidence obtained from various study designs, but randomized trials are usually considered most important for making recommendations about therapeutic and preventive interventions. This study evaluated the extent to which randomized trials are cited in guidelines published in major journals. The references of 191 guidelines of therapeutic and/or preventive interventions published in Annals of Internal Medicine, BMJ, JAMA, Lancet, NEJM and Pediatrics in 1979, 1984, 1989, 1994, and 1999, were analyzed. The percentage of guidelines not citing any randomized controlled trials (RCTs) decreased gradually from 95% in 1979 to 53% in 1999. Among 4,853 references of the guidelines, there were 393 RCTs (8.1% of total), 19 systematic reviews (0.4%), and 23 meta-analyses of RCTs (0.5%). Among 19 guidelines published in 1999 or 1994 with <2 RCTs cited, in eight cases additional pertinent RCTs were identified that had not been cited by the guideline. There is a clear increase in the use of randomized evidence by guidelines over time. However, several guidelines in major journals still cite few or no RCTs.

Entities:  

Mesh:

Year:  2002        PMID: 12063096     DOI: 10.1016/s0895-4356(02)00395-5

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  5 in total

Review 1.  A critical review of guidelines for low back pain treatment.

Authors:  Josep M Arnau; Antoni Vallano; Anna Lopez; Ferran Pellisé; Maria J Delgado; Nuria Prat
Journal:  Eur Spine J       Date:  2005-10-11       Impact factor: 3.134

2.  High methodologic quality but poor applicability: assessment of the AAOS guidelines using the AGREE II instrument.

Authors:  Sanjeeve Sabharwal; Nirav K Patel; Salman Gauher; Ian Holloway; Thanos Athanasiou; Thanos Athansiou
Journal:  Clin Orthop Relat Res       Date:  2014-02-25       Impact factor: 4.176

Review 3.  Guidelines in cardiac clinical practice: evaluation of their methodological quality using the AGREE II instrument.

Authors:  Sanjeeve Sabharwal; Vanash Patel; Sukhjinder S Nijjer; Ali Kirresh; Ara Darzi; John C Chambers; Iqbal Malik; Jaspal S Kooner; Thanos Athanasiou
Journal:  J R Soc Med       Date:  2013-05-28       Impact factor: 5.344

4.  Guidelines on chemotherapy in advanced stage gynecological malignancies: an evaluation of 224 professional societies and organizations.

Authors:  Nikolaos P Polyzos; Davide Mauri; John P A Ioannidis
Journal:  PLoS One       Date:  2011-05-17       Impact factor: 3.240

5.  Low Reporting of Cointerventions in Recent Cardiovascular Clinical Trials: A Systematic Review.

Authors:  Elisavet Moutzouri; Luise Adam; Martin Feller; Lamprini Syrogiannouli; Bruno R Da Costa; Cinzia Del Giovane; Douglas C Bauer; Drahomir Aujesky; Arnaud Chiolero; Nicolas Rodondi
Journal:  J Am Heart Assoc       Date:  2020-06-12       Impact factor: 5.501

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.